VIDAZA 100MG PD. FOR S.C INJ

Indication: Myelodysplastic Syndromes (MDS) . VIDAZA is indicated for treatment of patients with the following French-American-British (FAB) myelodysplastic syndrome subtypes: refractory anemia (RA) or refractory anemia with ringed sideroblasts (if accompanied by neutropenia or thrombocytopenia or requiring transfusions) refractory anemia with excess blasts (RAEB) refractory anemia with excess blasts in transformation (RAEB-T) and chronic myelomonocytic leukemia (CMMoL).